EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Prevalence of 25-Hydroxycholecalciferol Deficiency and Metabolic Syndrome in Croatian Women with Newly Diagnosed Breast Cancer

Katarina Vučić, Ljiljana Mayer, Ljilja Štefančić, Siniša Tomić, Iva Kirac, Mario Šekerija

Acta Clinica Croatica · 2025

DOI: 10.20471/acc.2025.64.01.02 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Acta Clinica Croatica, 2025. Verfasst von Katarina Vučić und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Safety and Efficacy Assessment of Medicinal products, Agency for Medicinal Products and Medical Devices, Zagreb, Croatia. Hauptthemen laut MEDLINE: Breast Neoplasms, Metabolic Syndrome, Vitamin D Deficiency, Calcifediol. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study was to determine the prevalence of vitamin D deficiency (VDD) and metabolic syndrome (MetS) including individual MetS components in Croatian women with newly diagnosed breast cancer (BC), exploring differences according to menopausal status. This cross-sectional, observational study recruited 203 adult female patients with newly diagnosed BC of any stage from all Croatian regions (median age 59, range 28-87 years), hospitalized consecutively for their first treatment between December 2016 and August 2017. We analyzed pretreatment fasting serum concentrations of 25-hydroxycholecalciferol (25(OH)D), high density lipoprotein, low density lipoprotein, triglycerides, plasma glucose, and measured systolic and diastolic blood pressure, weight and waist circumference; defining VDD as 25(OH)D concentrations

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMetabolic SyndromeVitamin D DeficiencyCalcifediolHumansFemaleMiddle AgedCroatiaAgedAdultPrevalenceCross-Sectional StudiesAged, 80 and over

Stichwörter der Autor:innen

Breast cancerCroatiaDeficiencyMetabolic syndromeVitamin D, 25-hydroxycholecalciferol

Substanzen

Calcifediol

Autor:innen und Institutionen

  • Department of Safety and Efficacy Assessment of Medicinal products, Agency for Medicinal Products and Medical Devices, Zagreb, Croatia.
  • Clinical Unit of Medical Chemistry in Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.
  • Department of Anesthesiology, Resuscitation and Intensive Care, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.
  • Directorate, Agency for Medicinal Products and Medical Devices, Zagreb, Croatia.
  • Department of Surgical Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.
  • Croatian National Cancer Registry, Department of Malignant Diseases, Croatian Institute of Public Health, Zagreb, Croatia.

Zitieren

APA

Vučić, K., Mayer, L., Štefančić, L., Tomić, S., Kirac, I., & Šekerija, M. (2025). Prevalence of 25-Hydroxycholecalciferol Deficiency and Metabolic Syndrome in Croatian Women with Newly Diagnosed Breast Cancer. Acta Clinica Croatica. https://doi.org/10.20471/acc.2025.64.01.02

Vancouver

Vučić K, Mayer L, Štefančić L, Tomić S, Kirac I, Šekerija M. Prevalence of 25-Hydroxycholecalciferol Deficiency and Metabolic Syndrome in Croatian Women with Newly Diagnosed Breast Cancer. Acta Clinica Croatica. 2025. doi:10.20471/acc.2025.64.01.02

BibTeX
@article{Vui2025,
  author = {Vučić, Katarina and Mayer, Ljiljana and Štefančić, Ljilja and Tomić, Siniša and Kirac, Iva and Šekerija, Mario},
  title = {Prevalence of 25-Hydroxycholecalciferol Deficiency and Metabolic Syndrome in Croatian Women with Newly Diagnosed Breast Cancer},
  journal = {Acta Clinica Croatica},
  year = {2025},
  doi = {10.20471/acc.2025.64.01.02}
}
Kostenlos starten →